|
Prime Minisiter of Senegal calls for free treatment for children with cancer |
|
 Geneva, Switzerland and Paris, France - July 1, 2009 –
Under the initiative of the International Union Against Cancer (UICC)
and sanofi-aventis, representatives from 21 countries have met in
Dakar, Senegal, on July 1 and 2, to review progress and strengthen
measures in the fight against cancer in low- and middle- income
countries, which began in 2004 through the “My Child Matters” programme.
|
|
Read more...
|
|
|
 Read the latest issue of the UICC eNews which has 14 new articles focused on HPV vaccination, the World Cancer Declaration, membership news, fellowships, campaigns and publications.
Read eNews
|
|
|
The Executive Director of UICC, Isabel Mortara, steps down |
|
 Geneva, 26 May 2009 – After 25 years with the UICC, including nine years as Executive Director, Isabel Mortara has announced that she will step down from her position in September 2009 to pursue other endeavours.
On behalf of the Board, UICC president, Dr David Hill, expressed his
deep appreciation for Isabel’s dedicated service and wide-reaching
contributions to global cancer control.
|
|
Read more...
|
|
|
Ask the Expert - World Cancer Declaration Target 2 |
|
 In July, Ask the Expert continues with Target 2 of the
World Cancer Declaration and its call for improving cancer surveillance
systems, in particular cancer registries.
Ask the Expert wants to hear from you on the state of
cancer registries in your country and welcomes comments on a number of interesting
questions.
|
|
Read more...
|
|
|
New Cancer Drug Shows "Promising Results" |
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
| Results 57 - 63 of 81 |
uicc | international union against cancer 
A landmark manifesto has been signed at the My Child Matters event in Dakar as a commitment to fight childhood cancer in low- and middle- income countries.
24 June- In a study, led by the Institute of Cancer
Research, scientists say a new type of cancer treatment, olaparib, has produced
highly promising results in preliminary drug trials. Mutations of BRCA1 and BCRA2 genes are directly linked to a
higher risk of breast, ovarian and prostate cancer. These genes may be one of
the causes for families who have multiple generations affected with the same
cancer.
> Congress 2010